Medical News: Imatinib Normalizes Life Expectancy in CML - in Oncology/Hematology, Leukemia from MedPage Today

Links shared publicly online about this topic.

  • 414
    total visits

Medical News: Imatinib Normalizes Life Expectancy in CML - in Oncology/Hematology, Leukemia from MedPage Today

medpagetoday.com —

Patients with chronic myeloid leukemia who respond to initial treatment with imatinib (Gleevec) now have a normal life expectancy, researchers reported.

View full resource at medpagetoday.com

Tags: Leukemia, Leukemia Medication, Chronic Myelogenous Leukemia, Gleevec, Glivec, News, Medical

  • Share

Most Recently Shared on March 25, 2011 at 2:41 pm By:

JackARothMD Jack A. Roth, M.D.

CML patients responding to imatinib have normal life expectancy http://bit.ly/h92jc5

1 year ago...

Reply

Retweet

Favorite

Also Shared By:

Medical News Medical News

Advertisement